DHL Express delivers US donation of Pfizer-BioNTech vaccines to Malaysia

0
374
DHL Express Vaccine

DHL Express, the world’s leading logistics provider, has successfully delivered the United States government’s donation of the Pfizer-BioNTech vaccine.

The arrival of around 1,000,000 doses comes from a recent commitment by the U.S. to assist with recovery efforts worldwide. This shipment is made possible via the COVAX global vaccine sharing programme to accelerate global equitable access to immunisation against the pandemic.

“We are deeply honoured by the trust that our customers have placed in us, and I’m incredibly proud that the team has yet again stepped up to deliver another batch of COVID-19 vaccines to Malaysia successfully. However, as DHL Express continues to leverage our global network and strong medical logistics expertise to ensure that these life-saving vaccines arrive safely and promptly, we must also remind ourselves of the need for collaboration amongst various parties and countries to manage this public health crisis effectively,” said Ken Lee, CEO, DHL Express Asia Pacific.

DHL Express arranged to collect the vaccines from facilities in the US before it was airlifted from our Cincinnati Hub to the DHL Express Subang Gateway, where it would be distributed to designated locations in Kuala Lumpur. From door-to-door, the journey spanned only four days in complete compliance with stringent handling and storage requirements.

“To date, DHL has transported more than 300 million doses of approved vaccines worldwide, five million of which were to Malaysia,” said Julian Neo, Managing Director of DHL Express Malaysia and Brunei. “The shipment today marks another milestone in combatting the spread of COVID-19 and contributing to the country’s recovery. In keeping with our mandate of connecting people and improving lives, we are proud to continue playing an active role in seeking a safe, new normal for the businesses and communities we serve.”

More than 9,000 life sciences and healthcare specialists work across DHL’s dedicated global network so that pharmaceutical, medical devices, clinical trials and research organisations, wholesalers and distributors, as well as hospitals and healthcare providers, are connected across the value chain and through digitalisation, from clinical trials to the point of care, and every step in between.

DHL’s portfolio for the healthcare industry includes 150+ pharmacists, 20+ clinical trials depots, 100+ certified stations, 160+ GDP-qualified warehouses, 15+ GMP-certified sites, 135+ medical express sites, and a time-definite international express network covering over 220 countries and territories. On a global scale, logistics providers are challenged to rapidly establish a medical supply chain to deliver vaccines of an unprecedented amount of more than 10 billion doses worldwide—also in regions with less developed logistics infrastructures, approximately 3 billion people live. To provide global coverage over the next two years, DHL estimated in its vaccine logistics whitepaper that up to 200,000 pallet shippers and 15 million cooling boxes, as well as 15,000 flights, will be required across the various supply chain setups.

อัพเดตข่าวสารและบทความที่น่าสนใจในอุตสาหกรรมโลจิสติกส์ก่อนใคร ผ่าน Line Official Account @Airfreight Logistics เพียงเพิ่มเราเป็นเพื่อน @Airfreight Logistics หรือคลิกที่นี่